| Schedule of Computation of Basic and Diluted Net Loss Per Share |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders:
Schedule
of Computation of Basic and Diluted Net Loss Per Share
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| |
|
(In thousands, except share and per share data) |
|
|
(In thousands, except share and per share data) |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(13,756 |
) |
|
$ |
(172 |
) |
|
$ |
(39,167 |
) |
|
$ |
(28,486 |
) |
| Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic weighted average shares outstanding |
|
|
14,041,712 |
|
|
|
565,026 |
|
|
|
13,721,680 |
|
|
|
534,381 |
|
| Diluted weighted average shares outstanding |
|
|
14,041,712 |
|
|
|
565,026 |
|
|
|
13,721,680 |
|
|
|
534,381 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
$ |
(0.98 |
) |
|
$ |
(0.30 |
) |
|
$ |
(2.85 |
) |
|
$ |
(53.31 |
) |
| Diluted |
|
$ |
(0.98 |
) |
|
$ |
(0.30 |
) |
|
$ |
(2.85 |
) |
|
$ |
(53.31 |
) |
|
The
following table sets forth the computation of the Company’s basic and diluted net income (loss) per share to common stockholders:
Schedule
of Computation of Basic and Diluted Net Loss Per Share
| |
|
2024 |
|
|
2023 |
|
| |
|
December
31, |
|
| |
|
2024 |
|
|
2023 |
|
| |
|
(In
thousands, except share per share data) |
|
| Numerator: |
|
|
|
|
|
|
|
|
| Net
income (loss) |
|
$ |
(73,297 |
) |
|
$ |
(135,139 |
) |
| |
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
|
| Basic weighted average
shares outstanding |
|
|
847,265 |
|
|
|
375,922 |
|
| Effect
of dilutive securities: |
|
|
|
|
|
|
|
|
| Common
stock warrants |
|
|
— |
|
|
|
— |
|
| Restricted
stock units |
|
|
— |
|
|
|
— |
|
| Common
stock options |
|
|
— |
|
|
|
— |
|
| Diluted weighted average
shares outstanding |
|
|
847,265 |
|
|
|
375,922 |
|
| |
|
|
|
|
|
|
|
|
| Net income (loss) per
share |
|
|
|
|
|
|
|
|
| Basic |
|
$ |
(86.51 |
) |
|
$ |
(359.49 |
) |
| Diluted |
|
$ |
(86.51 |
) |
|
$ |
(359.49 |
) |
|
| Schedule of Potentially Dilutive Shares Excluded from Computation of Net Loss Per Share |
The
following potentially dilutive shares of common stock equivalents “on an as-converted basis” were excluded from the computation
of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:
Schedule of Potentially Dilutive Shares Excluded from Computation of Net Loss Per Share
| |
|
For
the Three and Six Months Ended
June 30, |
|
|
| |
|
2025 |
|
|
2024 |
|
|
| |
|
|
|
|
|
|
|
| Common
stock warrants |
|
|
36,892 |
|
|
|
207,417 |
|
|
| Common
stock options |
|
|
9,971 |
|
|
|
20,808 |
|
|
| Restricted
stock units |
|
|
303,577 |
|
|
|
36,384 |
|
|
| Total
potentially dilutive common share equivalents |
|
|
350,440 |
|
|
|
264,609 |
|
|
|
The
following potentially dilutive shares of common stock equivalents on an “as-converted basis” were excluded from the computation
of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:
Schedule of Potentially Dilutive Shares Excluded from Computation of Net Loss Per Share
| |
|
December 31, |
|
| |
|
2024 |
|
|
2023 |
|
| |
|
(per share data) |
|
| Common stock warrants |
|
|
215,134 |
|
|
|
97,039 |
|
| Restricted stock units |
|
|
38,028 |
|
|
|
38,222 |
|
| Common stock options |
|
|
18,036 |
|
|
|
25,053 |
|
| Total potentially dilutive common share equivalents |
|
|
271,198 |
|
|
|
160,314 |
|
|